BI

Bioceres Crop Solutions Corp.

BIOXBasic MaterialsNASDAQ

Agricultural Inputs · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$333.3M
-28.3% YoY
Net Income
-$55.4M
-1396.1% YoY
EBITDA
-$9.8M
-117.3% YoY

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 9.0, below 30, stock may be oversold
Oct 19CONFIRMED▲ RSI OversoldRSI 9.8, below 30, stock may be oversold
About Bioceres Crop Solutions Corp.

Headquartered within the basic materials sector, Bioceres Crop Solutions Corp. focuses on Agricultural Inputs services and products. Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. The $15.0M market capitalization puts BIOX squarely in micro-cap range for its industry. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments.

Where BIOX stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, BIOX finished 36.59% below its 150-day moving average ($0.41) and 50.00% below its 200-day moving average ($0.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is BIOX overbought or oversold?

At the October 20, 2026 close, BIOX's RSI(14) was 9.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$15.0M
Fwd P/E0.37
EPS$-0.68
Beta0.47
52W Change-87.2%
Dividend Yield0.00%
ROE-28.1%
Analysis

Bioceres Crop Solutions Corp. carries $236.8M in total debt against $12.2M in cash reserves — debt is roughly 19.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Return on equity stands at -28.1%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been relatively flat, moving from $328.5M (2022) to $333.3M (2025).

BIOX's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Bioceres Crop Solutions Corp. and its sector.

Links
More Basic Materials stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms